Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Alere Inc    ALR

Delayed Quote. Delayed  - 08/26 10:02:04 pm
39.55 USD   -2.80%
08/26DJALERE : Sues Abbott to Force Merger -- 2nd Update
08/26 Alere drags Abbott to court over $5.8 billion deal
08/26DJALERE : Sues Abbott to Force Merger -- Update
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Alere Inc : Alere Inc. Schedules Conference Call for 8:30 a.m. ET February 8, 2012 to Discuss Fourth Quarter 2011 Results

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/01/2012 | 09:20pm CEST

WALTHAM, Mass., Feb. 1, 2012 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, today announced that it will release its fourth quarter 2011 earnings on Wednesday, February 8, 2012. The Company will also host a conference call beginning at 8:30 a.m. (Eastern Time) on that date to discuss these results and other corporate matters. During the conference call, the Company will discuss and answer questions concerning business and financial developments and trends. The Company's responses to questions, as well as other matters discussed during the conference call, may contain or constitute information that has not been disclosed previously.

The conference call may be accessed by dialing (800) 860-2442 (domestic) or (412) 858-4600 (international) and asking for Alere Inc. A webcast of the call can also be accessed via the Alere website at www.alere.com/investors, or directly through the following link: http://www.videonewswire.com/event.

A replay will be available approximately four hours after the conclusion of the call and will remain available for a period of seven days following the call. The replay may be accessed by dialing (877) 344-7529 (domestic) or (412) 317-0088 (international) and entering replay code 10009812. The replay will also be available via online webcast at http://www.videonewswire.com/event or via the Alere website at www.alere.com/investors for a period of 60 days following the call.

By developing new capabilities in near-patient diagnosis, monitoring and health management, Alere enables individuals to take charge of improving their health and quality of life at home. Alere's global leading products and services, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, toxicology and women's health. Alere is headquartered in Waltham, Massachusetts.

For additional information on Alere, please visit www.alere.com.

SOURCE Alere Inc.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ALERE INC
08/26DJALERE : Sues Abbott to Force Merger -- 2nd Update
08/26 Alere drags Abbott to court over $5.8 billion deal
08/26DJALERE : Sues Abbott to Force Merger -- Update
08/26DJALERE : Sues Abbott to Force Merger
08/26DJALERE : Sues Abbott Laboratories to Force Merger
08/26 ALERE : Issues Statement
08/25 ALERE : Receives FDA Clearance for Alere i RSV Rapid Molecular Test
08/19 ALERE : Receives FDA Clearance for Alere™ i RSV Rapid Molecular Test
08/19 ALERE : Receives FDA Clearance for Alere(TM) i RSV Rapid Molecular Test
08/18 ALERE INC. : Entry into a Material Definitive Agreement, Financial Statements an..
More news
Sector news : Advanced Medical Equipment & Technology - NEC
08/17DJAGILENT TECHNOLOGIES : Tech Tapers Annual Outlook Amid Slowing Life Sciences Sal..
08/15DJFisher & Paykel Files Patent Infringement Claim Against ResMed
08/02DJCERNER : Edges Annual Revenue Guidance Lower
07/29DJSony Reports Surprise Profit
07/28DJU.S. HOT STOCKS : Hot Stocks to Watch
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
08/26 Alere files lawsuit to force Abbott to complete acquisition
08/19 FDA OKs Alere's rapid molecular RSV test
08/17 How Ford Plans To Crush Tesla
08/17 Alere revenues off 6% in Q1
08/17 Alere reports Q1 results